How Do Biomarkers Help Distinguish ADHD from Other Disorders?

PostedOctober 7, 2025

UpdatedOctober 10, 2025

ByMy Patient Advice

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Diagnosing ADHD can be complicated by comorbid conditions like autism, anxiety, or bipolar disorder, which often share overlapping symptoms such as impulsivity, inattention, or emotional dysregulation. That is where ADHD differential biomarkers come into play, offering a potential way to biologically separate ADHD from lookalike disorders.

Why Biomarkers Matter in Complex Cases

While current ADHD diagnosis relies on clinical observation and behavioural checklists, researchers are investigating whether biomarkers, objective biological indicators, can support more precise differentiation. The goal is to develop tools that identify unique neurochemical or neurophysiological signatures of ADHD, making it easier to distinguish from conditions with similar outward symptoms.

For example:

In ADHD, altered dopamine transporter function and reduced norepinephrine activity are often seen.

In anxiety disorders, biomarkers may instead show heightened cortisol and stress reactivity.

Autism may involve different genetic and inflammatory markers, and less consistent dopamine abnormalities.

Bipolar disorder can mimic ADHD in its early stages but shows different mood-related biomarker patterns, especially in neurotransmitter cycling.

The Future of Differential Diagnosis

Emerging technologies like EEG patterns, PET imaging, or blood-based markers may one day assist in identifying ADHD-specific biomarkers, particularly in individuals with comorbid psychiatric conditions.

Conclusion

While not yet part of routine diagnosis, ADHD differential biomarkers may help clinicians untangle complex cases involving anxiety, autism, or bipolar symptoms, leading to more accurate care.

Visit providers like ADHD Certify for personal consultations exploring the use of biological tools in distinguishing ADHD from other disorders.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic studies and biomarkers.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.